NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Verve Therapeutics, Inc. (NASDAQ: VERV) on behalf of the company's shareholders. The investigation seeks to determine whether Verve Therapeutics's directors breached their fiduciary duties in connection with recent corporate actions.If you are a shareholder of Verve Therapeutics, Inc. and are interested in obtaining additional information regarding your rights and options, free of charge, please visit us at: ht ...